Zeynep Madak Erdogan

Photo of promotional displays, with a picture from the ENDO2024 poster session

Photo of the video banner over the registration booths, includes a photo from ENDO2024 of a group of faculty from the NR IMPACT group

If you're wondering, yes, @endocrinesociety.bsky.social will use your pictures for promo material 😂 #ENDO2025

Pretty cool to have @nrimpact.bsky.social folks featured:
@profriggins.bsky.social
@zmadake2.bsky.social
@ayeshashafi.bsky.social
@cittellylab.bsky.social
Drs Cordoba-Chacon & Treviño

12.07.2025 17:54 — 👍 19    🔁 5    💬 0    📌 0

Looking forward to receiving some of these manuscripts. #JES

08.05.2025 01:31 — 👍 3    🔁 1    💬 0    📌 0

Journals Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Notice to Authors with the NIEHS Journal, Environmental Health Perspectives (EHP) | We welcome submissions or transfers of manuscripts now in process at EHP: #JES (Open Access, clinical and basic), and #Endocrinology (basic). Fees can be waived. Email publications@endocrine.org: bit.ly/2yCrRBi

07.05.2025 20:36 — 👍 9    🔁 4    💬 1    📌 0

Thank you Sean for the shout out🙏🏻🙏🏻🙏🏻

31.01.2025 00:25 — 👍 2    🔁 0    💬 0    📌 0

Thanks Becca🙏🏻🙏🏻🙏🏻

16.01.2025 01:08 — 👍 2    🔁 0    💬 0    📌 0

A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasiv... Matthew J Sikora, Julie H Ostrander; A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasive lobular carcinoma, Jo

@jostrander.bsky.social and I had the opportunity to write a commentary on @profriggins.bsky.social latest work in JES - @zmadake2.bsky.social - looking toward really cool implications for understanding and leveraging the unique metabolism of lobular breast cancer.

academic.oup.com/jes/advance-...

02.01.2024 15:24 — 👍 12    🔁 4    💬 1    📌 0